Eric Evans has been appointed chief financial officer of the newly merged companies, AAIPharma Services and Cambridge Major Laboratories (AAI-CML). Mr. Evans brings more than 25 years of financial leadership experience. Most recently, he served as chief financial officer of AAIPharma Services, and prior to that, he was chief financial officer and executive vice president of Patheon , Inc., and vice president and controller for Novartis Pharmaceuticals. He also served as chief financial officer for the U.S. division of Sandoz.
“Eric’s extensive financial experience in both the pharmaceutical and contract services sectors and his ability to work in a client-centered business structure make him a natural fit as chief financial officer of the merged company,” said Patrick Walsh, chief executive officer of AAI-CML. “He brings leadership and experience managing contract development and manufacturing organizations through scalable growth.”